Credit Suisse analyst A.J. Rice raised the firm’s price target on UnitedHealth to $610 from $590 as he makes no changes to his EPS estimates but rolls forward his valuation to 2024. The analyst keeps an Outperform rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on UNH:
- Citron goes short Agilon, says Supreme Court ‘torpedoed’ business
- Craig-Hallum upgrades eHealth to Buy on ‘clear signs of life’
- Managed care company returns will be tough to keep replicating, WSJ says
- UnitedHealth backs FY22 adjusted EPS view $21.85-$22.05, consensus $22.03
- UnitedHealth sees FY23 adjusted EPS $24.40-$24.90, consensus $24.94